Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 1Glioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × RMP 7 × Clear all
NCT00005602 2014-02-21

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Children's Oncology Group

Phase 1 Completed
13 enrolled
CNS

Central Nervous System Neoplasms

NCT00001502 2008-03-04

A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
CNS

Brain Neoplasms, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡